CVS/Caremark merger wins ISS approval

THE CVS/CAREMARK merger proposal announced in November by Thomas M. Ryan, left, president and CEO of CVS, and Mac Crawford, his  Caremark Rx counterpart, has won the endorsement of advisory service ISS. /
THE CVS/CAREMARK merger proposal announced in November by Thomas M. Ryan, left, president and CEO of CVS, and Mac Crawford, his Caremark Rx counterpart, has won the endorsement of advisory service ISS. /
NASHVILLE, Tenn. – Caremark Rx. Inc. (NYSE: CMX) today announced that Institutional Shareholder Services, an independent proxy voting advisory service, is now advising clients to support Caremark’s pending merger with CVS Corp. (NYSE: CVS). ISS, whose clients include hundreds of institutional investors, mutual funds, money managers and other fiduciaries, previously had advised its clients against…

Want More?

Subscribe or register with Providence Business News to keep reading.

REGISTER
for 2 more stories

Subscribe now for $1 for 4 weeks
Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -